Published in Neuroscience on June 11, 2010
GABA neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia. Neural Plast (2011) 1.51
Rethinking schizophrenia in the context of normal neurodevelopment. Front Cell Neurosci (2013) 1.33
Postsynaptic diacylglycerol lipase mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex. J Physiol (2011) 1.32
Cortical basket cell dysfunction in schizophrenia. J Physiol (2012) 1.22
New dimensions of interneuronal specialization unmasked by principal cell heterogeneity. Trends Neurosci (2011) 1.20
Postnatal developmental trajectories of neural circuits in the primate prefrontal cortex: identifying sensitive periods for vulnerability to schizophrenia. Schizophr Bull (2011) 1.20
Perisomatic inhibition and cortical circuit dysfunction in schizophrenia. Curr Opin Neurobiol (2011) 1.09
Differential distribution of proteins regulating GABA synthesis and reuptake in axon boutons of subpopulations of cortical interneurons. Cereb Cortex (2011) 1.07
Dose-related modulation of event-related potentials to novel and target stimuli by intravenous Δ⁹-THC in humans. Neuropsychopharmacology (2012) 1.01
Neurodevelopment, GABA system dysfunction, and schizophrenia. Neuropsychopharmacology (2014) 0.96
Susceptibility of the adolescent brain to cannabinoids: long-term hippocampal effects and relevance to schizophrenia. Transl Psychiatry (2012) 0.92
Endocannabinoid metabolism in the prefrontal cortex in schizophrenia. Schizophr Res (2013) 0.90
Disruption of frontal θ coherence by Δ9-tetrahydrocannabinol is associated with positive psychotic symptoms. Neuropsychopharmacology (2010) 0.89
Acquisition and baseline performance of working memory tasks by adolescent rhesus monkeys. Brain Res (2011) 0.89
Developmental trajectory of the endocannabinoid system in human dorsolateral prefrontal cortex. BMC Neurosci (2012) 0.88
The dynamic nature of type 1 cannabinoid receptor (CB(1) ) gene transcription. Br J Pharmacol (2012) 0.88
Cortical glutamic acid decarboxylase 67 deficiency results in lower cannabinoid 1 receptor messenger RNA expression: implications for schizophrenia. Biol Psychiatry (2011) 0.86
Correlative analysis of immunoreactivity in confocal laser-scanning microscopy and scanning electron microscopy with focused ion beam milling. Front Neural Circuits (2013) 0.86
The effect of chronic cannabinoids on broadband EEG neural oscillations in humans. Neuropsychopharmacology (2012) 0.85
Impact of Cannabis Use on the Development of Psychotic Disorders. Curr Addict Rep (2014) 0.85
Association of Cannabis Use during Adolescence, Prefrontal CB1 Receptor Signaling, and Schizophrenia. Front Pharmacol (2012) 0.85
Layer 3 Excitatory and Inhibitory Circuitry in the Prefrontal Cortex: Developmental Trajectories and Alterations in Schizophrenia. Biol Psychiatry (2016) 0.83
The role of cannabinoid 1 receptor expressing interneurons in behavior. Neurobiol Dis (2013) 0.81
Different Paths to Core Pathology: The Equifinal Model of the Schizophrenia Syndrome. Schizophr Bull (2015) 0.79
New insights on endocannabinoid transmission in psychomotor disorders. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.79
Loss of Either Rac1 or Rac3 GTPase Differentially Affects the Behavior of Mutant Mice and the Development of Functional GABAergic Networks. Cereb Cortex (2015) 0.78
Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivity and transcript levels in schizophrenia. Schizophr Res (2014) 0.78
Δ9-THC Disrupts Gamma (γ)-Band Neural Oscillations in Humans. Neuropsychopharmacology (2015) 0.78
Mechanisms contributing to prefrontal cortex maturation during adolescence. Neurosci Biobehav Rev (2016) 0.77
Functional properties of GABA synaptic inputs onto GABA neurons in monkey prefrontal cortex. J Neurophysiol (2014) 0.77
Resting state functional magnetic resonance imaging reveals distinct brain activity in heavy cannabis users - a multi-voxel pattern analysis. J Psychopharmacol (2014) 0.76
Cannabinoid modulation of backpropagating action potential-induced calcium transients in layer 2/3 pyramidal neurons. Cereb Cortex (2012) 0.76
Disrupted gamma-band neural oscillations during coherent motion perception in heavy cannabis users. Neuropsychopharmacology (2014) 0.76
The Role of Endocannabinoid Signaling in Cortical Inhibitory Neuron Dysfunction in Schizophrenia. Biol Psychiatry (2015) 0.76
GABA Deficits Enhance the Psychotomimetic Effects of Δ9-THC. Neuropsychopharmacology (2015) 0.76
Ultrastructural evidence for synaptic contacts between cortical noradrenergic afferents and endocannabinoid-synthesizing post-synaptic neurons. Neuroscience (2015) 0.75
Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem (1981) 38.93
Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci (2005) 11.68
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet (2007) 11.27
Cellular basis of working memory. Neuron (1995) 8.22
Role of endogenous cannabinoids in synaptic signaling. Physiol Rev (2003) 5.70
Asynchronous GABA release generates long-lasting inhibition at a hippocampal interneuron-principal neuron synapse. Nat Neurosci (2005) 4.77
Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci (1999) 4.65
An open letter to our readers on the use of antibodies. J Comp Neurol (2005) 3.86
Perisomatic inhibition. Neuron (2007) 3.79
Electrical synapses in the mammalian brain. Annu Rev Neurosci (2004) 3.66
Gamma oscillations correlate with working memory load in humans. Cereb Cortex (2003) 3.37
Cannabinoids reveal importance of spike timing coordination in hippocampal function. Nat Neurosci (2006) 3.09
Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ (2004) 2.93
Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci (1999) 2.92
Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry (2007) 2.91
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology (2004) 2.87
Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci (2006) 2.81
Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci (1998) 2.81
Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci (2000) 2.69
The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum. J Neurosci (2006) 2.66
Complementary roles of cholecystokinin- and parvalbumin-expressing GABAergic neurons in hippocampal network oscillations. J Neurosci (2005) 2.64
Distinct timing in the activity of cannabinoid-sensitive and cannabinoid-insensitive basket cells. Nat Neurosci (2006) 2.59
Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience (1997) 2.56
Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types. J Neurosci (2005) 2.32
GAD67-mediated GABA synthesis and signaling regulate inhibitory synaptic innervation in the visual cortex. Neuron (2007) 2.23
Magic peptides, magic antibodies: guidelines for appropriate controls for immunohistochemistry. J Comp Neurol (2003) 2.14
Destruction and creation of spatial tuning by disinhibition: GABA(A) blockade of prefrontal cortical neurons engaged by working memory. J Neurosci (2000) 2.13
Neurochemical features and synaptic connections of large physiologically-identified GABAergic cells in the rat frontal cortex. Neuroscience (1998) 2.07
Cannabis, the mind and society: the hash realities. Nat Rev Neurosci (2007) 1.99
Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats. Neuropsychopharmacology (2003) 1.97
Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature (2004) 1.92
Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. Cereb Cortex (2006) 1.85
Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling. Nat Neurosci (2009) 1.77
Cell type-specific gating of perisomatic inhibition by cholecystokinin. Nat Neurosci (2007) 1.73
Targets of horizontal connections in macaque primary visual cortex. J Comp Neurol (1991) 1.71
Electrical coupling among irregular-spiking GABAergic interneurons expressing cannabinoid receptors. J Neurosci (2004) 1.68
Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia. Arch Gen Psychiatry (2008) 1.64
Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB. J Comp Neurol (2000) 1.58
Synaptic cross talk between perisomatic-targeting interneuron classes expressing cholecystokinin and parvalbumin in hippocampus. J Neurosci (2009) 1.47
Distribution and patterns of connectivity of interneurons containing calbindin, calretinin, and parvalbumin in visual areas of the occipital and temporal lobes of the macaque monkey. J Comp Neurol (1999) 1.37
Localization of calcium-binding proteins in physiologically and morphologically characterized interneurons of monkey dorsolateral prefrontal cortex. Cereb Cortex (2004) 1.36
Local circuit neurons of developing and mature macaque prefrontal cortex: Golgi and immunocytochemical characteristics. J Comp Neurol (1993) 1.34
Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: relevance to schizophrenia. Biol Psychiatry (2008) 1.30
Postnatal development of pre- and postsynaptic GABA markers at chandelier cell connections with pyramidal neurons in monkey prefrontal cortex. J Comp Neurol (2003) 1.29
Monoclonal antibodies directed against the calcium binding protein parvalbumin. Cell Calcium (1988) 1.28
Synaptic connections of intracellularly filled clutch cells: a type of small basket cell in the visual cortex of the cat. J Comp Neurol (1985) 1.23
Axon terminals immunolabeled for dopamine or tyrosine hydroxylase synapse on GABA-immunoreactive dendrites in rat and monkey cortex. J Comp Neurol (1995) 1.22
Localisation of gastrins to neuro- and adenohypophysis. Nature (1978) 1.19
Endocannabinoid signalling selectively targets perisomatic inhibitory inputs to pyramidal neurones in juvenile mouse neocortex. J Physiol (2004) 1.19
Cannabinoid ligands and their effects on learning and performance in rhesus monkeys. Behav Pharmacol (1999) 1.17
Cholecystokinin inhibits endocannabinoid-sensitive hippocampal IPSPs and stimulates others. Neuropharmacology (2007) 1.10
Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission. Eur J Neurosci (2007) 1.08
An immunohistochemical characterization of somatostatin-28 and somatostatin-281-12 in monkey prefrontal cortex. J Comp Neurol (1986) 1.02
Delayed response deficit in monkeys by locally disturbed prefrontal neuronal activity by bicuculline. Behav Brain Res (1988) 1.02
Gastrin is a major mediator of the gastric phase of acid secretion in dogs: proof by monoclonal antibody neutralization. Gastroenterology (1989) 1.01
Two distinct subgroups of cholecystokinin-immunoreactive cortical interneurons. Brain Res (1997) 1.00
Heterogeneous targets of dopamine synapses in monkey prefrontal cortex demonstrated by serial section electron microscopy: a laminar analysis using the silver-enhanced diaminobenzidine sulfide (SEDS) immunolabeling technique. Cereb Cortex (1993) 0.96
Synaptic targets of calretinin-containing axon terminals in macaque monkey prefrontal cortex. Neuroscience (2005) 0.93
Distinct differences in the cannabinoid receptor binding in the brain of C57BL/6 and DBA/2 mice, selected for their differences in voluntary ethanol consumption. J Neurosci Res (2000) 0.92
Postnatal development of the cholecystokinin innervation of monkey prefrontal cortex. J Comp Neurol (1993) 0.90
Cholecystokinin-immunoreactive neurons in rat and monkey cerebral cortex make symmetric synapses and have intimate associations with blood vessels. Proc Natl Acad Sci U S A (1983) 0.89
Regional distribution of cholecystokinin-like immunoreactivity in the human brain. J Clin Endocrinol Metab (1981) 0.82
Cholecystokinin innervation of monkey prefrontal cortex: an immunohistochemical study. J Comp Neurol (1990) 0.81
Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry (2000) 6.91
Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron (2000) 4.29
Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell (1997) 3.99
Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry (2000) 3.44
Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices. J Neurosci (1987) 3.39
Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. Proc Natl Acad Sci U S A (1996) 3.17
Localization of amyloid beta protein messenger RNA in brains from patients with Alzheimer's disease. Science (1987) 3.07
Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. J Virol (1999) 3.02
Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J Neurosci (2000) 2.91
Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry (2007) 2.91
Protoplasmic Streaming in Plants Sensitive and Insensitive to Chilling Temperatures. Science (1956) 2.85
Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. Am J Psychiatry (1995) 2.73
Yeast sugar transporters. Crit Rev Biochem Mol Biol (1993) 2.43
The Sar1 GTPase coordinates biosynthetic cargo selection with endoplasmic reticulum export site assembly. J Cell Biol (2001) 2.41
Local circuit neurons immunoreactive for calretinin, calbindin D-28k or parvalbumin in monkey prefrontal cortex: distribution and morphology. J Comp Neurol (1994) 2.25
A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci U S A (1998) 2.00
Molecular mechanisms contributing to dendritic spine alterations in the prefrontal cortex of subjects with schizophrenia. Mol Psychiatry (2006) 1.99
Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse. Trends Neurosci (2001) 1.98
Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization. J Comp Neurol (2001) 1.95
Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol Psychiatry (2001) 1.94
Dendritic spine pathology in schizophrenia. Neuroscience (2012) 1.91
An outbreak of Burkholderia (formerly Pseudomonas) cepacia respiratory tract colonization and infection associated with nebulized albuterol therapy. Ann Intern Med (1995) 1.88
Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. Am J Psychiatry (1999) 1.86
GABA-containing neurons in the rat ventral tegmental area project to the prefrontal cortex. Synapse (2000) 1.78
Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc Natl Acad Sci U S A (1996) 1.75
Summary of proceedings of the IUSTI Global Challenges Symposium (ISSTDR 2007/10th IUSTI World Congress). Int J STD AIDS (2009) 1.73
A second-generation, endoluminal, flow-disrupting device for treatment of saccular aneurysms. AJNR Am J Neuroradiol (2009) 1.67
Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatry (2010) 1.66
Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent. J Virol (2001) 1.65
Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature. J Affect Disord (1983) 1.65
Postnatal maturation of the dopaminergic innervation of monkey prefrontal and motor cortices: a tyrosine hydroxylase immunohistochemical analysis. J Comp Neurol (1995) 1.65
Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J Clin Invest (1997) 1.62
Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. Am J Psychiatry (1999) 1.60
Controlled prospective study of postpartum mood disorders: psychological, environmental, and hormonal variables. J Abnorm Psychol (1991) 1.60
Synchronous development of pyramidal neuron dendritic spines and parvalbumin-immunoreactive chandelier neuron axon terminals in layer III of monkey prefrontal cortex. Neuroscience (1995) 1.55
Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. Arch Gen Psychiatry (2001) 1.54
Experience with microaneurysm formation at the basilar terminus in the rabbit elastase aneurysm model. AJNR Am J Neuroradiol (2009) 1.50
Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression. Mol Psychiatry (2011) 1.48
Over the counter anti-infectives--of benefit to whom? J Antimicrob Chemother (1995) 1.46
Mupirocin-resistant MRSA. J Hosp Infect (1994) 1.45
Hippocampal afferents to the rat prefrontal cortex: synaptic targets and relation to dopamine terminals. J Comp Neurol (1996) 1.44
Penile myiasis: a case report. Sex Transm Infect (2004) 1.44
Differential regulation of amyloid-beta-protein mRNA expression within hippocampal neuronal subpopulations in Alzheimer disease. Proc Natl Acad Sci U S A (1988) 1.43
Interpretation of blood films in diagnosis of malaria. Lancet (1989) 1.41
The management of lead exposure in pediatric populations. Nurse Pract (1990) 1.38
The reactivity of paired plasma and serum samples are comparable in the anticardiolipin and anti-beta2-glycoprotein-1 ELISAs. J Thromb Haemost (2006) 1.38
Anti-inflammatory actions of dapsone and its related biochemistry. J Pharm Pharmacol (1976) 1.36
Localization of calcium-binding proteins in physiologically and morphologically characterized interneurons of monkey dorsolateral prefrontal cortex. Cereb Cortex (2004) 1.36
Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons. Am J Psychiatry (1997) 1.36
Retrospective audit of the efficacy and safety of the combined intranasal/intravenous midazolam sedation technique for the dental treatment of adults with learning disability. Br Dent J (2008) 1.35
Patterns of intrinsic and associational circuitry in monkey prefrontal cortex. J Comp Neurol (1996) 1.35
Local circuit neurons of developing and mature macaque prefrontal cortex: Golgi and immunocytochemical characteristics. J Comp Neurol (1993) 1.34
Lamina-specific deficits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia: evidence for fewer projections from the thalamus. Am J Psychiatry (2001) 1.33
Dopamine increases excitability of pyramidal neurons in primate prefrontal cortex. J Neurophysiol (2000) 1.32
Immunolocalization of the cocaine- and antidepressant-sensitive l-norepinephrine transporter. J Comp Neurol (2000) 1.32
Prospective study of postpartum blues. Biologic and psychosocial factors. Arch Gen Psychiatry (1991) 1.31
Specificity and timing of neocortical transcriptome changes in response to BDNF gene ablation during embryogenesis or adulthood. Mol Psychiatry (2006) 1.30
Regional specificity of chandelier neuron axon terminal alterations in schizophrenia. Neuroscience (2005) 1.30
Management of clusters of meningococcal disease. PHIS Meningococcus Working Group and Public Health Medicine Environmental Group. Commun Dis Rep CDR Rev (1997) 1.30
The hierarchical development of monkey visual cortical regions as revealed by the maturation of parvalbumin-immunoreactive neurons. Brain Res Dev Brain Res (1996) 1.30
The distribution of tyrosine hydroxylase-immunoreactive fibers in primate neocortex is widespread but regionally specific. J Neurosci (1987) 1.29
Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons. Psychiatry Res (1995) 1.28
Horizontal synaptic connections in monkey prefrontal cortex: an in vitro electrophysiological study. Cereb Cortex (2000) 1.26
Glutamate synaptic inputs to ventral tegmental area neurons in the rat derive primarily from subcortical sources. Neuroscience (2007) 1.25
Properties of excitatory synaptic responses in fast-spiking interneurons and pyramidal cells from monkey and rat prefrontal cortex. Cereb Cortex (2005) 1.23
Axon terminals immunolabeled for dopamine or tyrosine hydroxylase synapse on GABA-immunoreactive dendrites in rat and monkey cortex. J Comp Neurol (1995) 1.22
Cloning and characterization of an AAC(6') gene from Serratia marcescens. J Antimicrob Chemother (1988) 1.22
Changes in the dopaminergic innervation of monkey prefrontal cortex during late postnatal development: a tyrosine hydroxylase immunohistochemical study. Biol Psychiatry (1994) 1.21
Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia. Biol Psychiatry (1999) 1.21
Lysosomal enzyme levels in the blood of arthritic rats. Biochem Pharmacol (1971) 1.21
Ultrastructural localization of serotonin2A receptors in the middle layers of the rat prelimbic prefrontal cortex. Neuroscience (2003) 1.21
Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. Arch Gen Psychiatry (1997) 1.20
Peripubertal refinement of the intrinsic and associational circuitry in monkey prefrontal cortex. Neuroscience (1997) 1.20
WHO global strategy for the prevention and control of sexually transmitted infections: time for action. Sex Transm Infect (2007) 1.19
Rhodococcus equi infection in foals: the science of 'rattles'. Equine Vet J (2007) 1.19
Insulin-like growth factor binding protein-4 protease produced by smooth muscle cells increases in the coronary artery after angioplasty. Arterioscler Thromb Vasc Biol (2001) 1.18
Factors affecting longevity of homograft valves used in right ventricular outflow tract reconstruction for congenital heart disease. Circulation (2000) 1.16
Balloon-assisted coiling of intracranial aneurysms: evaluation of local thrombus formation and symptomatic thromboembolic complications. AJNR Am J Neuroradiol (2007) 1.13
Topography of pyramidal neuron intrinsic connections in macaque monkey prefrontal cortex (areas 9 and 46). J Comp Neurol (1993) 1.12
Elevated 5-HT 2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase A. Neuroscience (2008) 1.09
Parvalbumin-immunoreactive axon terminals in macaque monkey and human prefrontal cortex: laminar, regional, and target specificity of type I and type II synapses. J Comp Neurol (1999) 1.06
A monoclonal antibody to non-phosphorylated neurofilament protein marks the vulnerable cortical neurons in Alzheimer's disease. Brain Res (1987) 1.06
Electrophysiological differences between neurogliaform cells from monkey and rat prefrontal cortex. J Neurophysiol (2006) 1.06
Genetic polymorphisms of the RGS4 and dorsolateral prefrontal cortex morphometry among first episode schizophrenia patients. Mol Psychiatry (2005) 1.06
Stabilising action of anti-inflammatory steroids on lysosomes. Biochem Pharmacol (1969) 1.05
Parvalbumin-positive basket interneurons in monkey and rat prefrontal cortex. J Neurophysiol (2008) 1.05
The stabilization-lysis action of anti-inflammatory steroids on lysosomes. J Pharm Pharmacol (1970) 1.05
Action of anti-inflammatory steroids on the lytic action of phospholipase C and 2,4,6-trinitrobenzene sulphonic acid on lysosomes. Biochem Pharmacol (1974) 1.03
Growth of human cytomegalovirus in primary macrophages. Methods (1998) 1.03
Synaptic targets of pyramidal neurons providing intrinsic horizontal connections in monkey prefrontal cortex. J Comp Neurol (1998) 1.03
Investigation of the interaction among the components of the cytolethal distending toxin of Haemophilus ducreyi. Biochem Biophys Res Commun (2001) 1.03
Dopamine axons in primate prefrontal cortex: specificity of distribution, synaptic targets, and development. Adv Pharmacol (1998) 1.02
Reactive dopamine metabolites and neurotoxicity: implications for Parkinson's disease. Adv Exp Med Biol (1996) 1.02
Endogenous anti-inflammatory factors. Biochem Pharmacol (1984) 1.02
An immunohistochemical characterization of somatostatin-28 and somatostatin-281-12 in monkey prefrontal cortex. J Comp Neurol (1986) 1.02
Traffic pattern of cystic fibrosis transmembrane regulator through the early exocytic pathway. Traffic (2000) 1.02